A new sandwich-based lateral flow immunoassay (LFIA) for the detection of Receptor Binding Domain (RBD) of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) could provide an efficient substitute for RT-PCR tests.
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.